Clopra and Fibrin d dimer increased - a phase IV clinical study of FDA data

Summary:

Fibrin d dimer increased is reported as a side effect among people who take Clopra (metoclopramide hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Morphine, and have Metastatic carcinoid tumor.

The phase IV clinical study analyzes which people have Fibrin d dimer increased when taking Clopra. It is created by eHealthMe based on reports of 80,974 people who have side effects when taking Clopra from the FDA, and is updated regularly.

What is Clopra?

Clopra has active ingredients of metoclopramide hydrochloride. eHealthMe is studying from 81,430 Clopra users. Check the latest studies of Clopra.

What is Fibrin d dimer increased?

Fibrin d dimer increased is found to be associated with 517 drugs and 834 conditions by eHealthMe. Check the latest studies of Fibrin d dimer increased.

On Jul, 12, 2026

80,974 people reported to have side effects when taking Clopra.
Among them, 54 people (0.07%) have Fibrin d dimer increased.

Could Clopra cause Fibrin d dimer increased?

Among these 54 people:

How long have people been on Clopra when they have Fibrin d dimer increased? *

What is the gender of people who have Fibrin d dimer increased when taking Clopra? *

female: 68.52 %
male: 31.48 %

What is the age of people who have Fibrin d dimer increased when taking Clopra? *

What are other drugs people take besides Clopra? *

What are other side effects people have besides Fibrin d dimer increased? *

Thrombocytopenia (decrease of platelets in blood): 22 people, 40.74%
Abdominal Pain: 21 people, 38.89%
Nausea (feeling of having an urge to vomit): 20 people, 37.04%
White Blood Cell Count Decreased: 18 people, 33.33%
Dizziness: 15 people, 27.78%
Pain In Extremity: 15 people, 27.78%
Dyspnea (difficult or laboured breathing): 14 people, 25.93%
Fainting (loss of consciousness and postural tone): 14 people, 25.93%
Anaemia (lack of blood): 13 people, 24.07%
Weakness: 13 people, 24.07%

What are the existing conditions these people have? *

Metastatic Carcinoid Tumor: 10 people, 18.52%
Neuroblastoma (a cancer that forms in your nerve tissue): 5 people, 9.26%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 5 people, 9.26%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 4 people, 7.41%
Nausea (feeling of having an urge to vomit): 4 people, 7.41%
Lung Cancer - Non-Small Cell (lung cancer): 4 people, 7.41%
Swallowing Difficulty: 3 people, 5.56%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 3 people, 5.56%
Nausea And Vomiting: 3 people, 5.56%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Clopra and have Fibrin d dimer increased?

- Check whether Fibrin d dimer increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Clopra:

Clopra (81,430 reports)

Browse all side effects of Clopra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fibrin d dimer increased:

Fibrin d dimer increased (517 drugs)

Browse all the conditions that are associated with Fibrin d dimer increased:

Fibrin d dimer increased (834 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on metoclopramide hydrochloride (the active ingredients of Clopra) and Clopra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.